Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-26 @ 10:32 AM
NCT ID:
NCT00862628
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* 20 to 85 years of age
* RA, OA, or low back pain
* No change of drugs before 3 months
* Under 5 mg of corticosteroid use
* CRP \< 1mg/dl
* Small-intestinal mucosal injuries more than one
* Hemoglobin level is below normal range
Exclusion Criteria:
* Known or suspected small-bowel disease, including Crohn's disease and seronegative arthritis
* Prostaglandins, metronidazole or salazosulfapyridine
* Can not swallow
* Eith pacemaker
* After gastrointestinal operation
* Serious concomitant cardiovascular, endocrine, gastrointestinal(including symptoms of ileus), neurologic, psychiatric, renal, or respiratory disease.
* Taking rebamipide before one week
* Any other conditions that the investigator feels would interfere with data interpretation or create under risk.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT00862628
Study Brief:
Protocol Section:
NCT00862628